NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/26/2025
Back to search
Official data from USPTO
RXDISPENSE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
06/27/2025
Trademark type
Word
Nice classes
42
Filing date
01/29/2018
Registration date
05/14/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/26/2025
Last transaction
06/27/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
11/01/2018
First use in commerce
11/01/2018
Drawing code
4
Owner type
03
Owner location
Houston, TX
Examiner
SANDER, DREW
Current location
Historical data usage
Holders and representatives
Holders
Professional Compounding Centers of America, Inc.
Representatives
Erin J. Werner Werner IP Law, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
providing temporary use of on-line non-downloadable software accessed via the Internet in the field of pharmacy managementfor formulating compounded prescriptionschecking the information associated with prescriptionsreceiving prescriptions electronically through the use of external applicationsbilling prescriptions through third party payersproviding medication shipment servicesproviding point-of-sale services for pharmaciesmanaging doctors and patientsinteracting with public master databasestracking drug interactionsmanaging drug and chemical inventoryproviding on-line ordering and receivingmanaging accreditationsauditing transactionsproducing reports; providing software as a service (SAAS) serviceshosting software for use by others for use in operating and managing a pharmacy
Publications
History of USPTO decisions and trademark events.
35 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/26/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/26/2025
ES8R
TEAS SECTION 8 RECEIVED
03/20/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/07/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/07/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/07/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/14/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/14/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/14/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/14/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/14/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/10/2019
ALIE
ASSIGNED TO LIE
04/05/2019
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
03/16/2019
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
03/15/2019
IUAA
USE AMENDMENT ACCEPTED
03/15/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2019
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
02/09/2019
IUAF
USE AMENDMENT FILED
02/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/08/2019
EAAU
TEAS AMENDMENT OF USE RECEIVED
02/08/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/19/2018
GNFR
FINAL REFUSAL E-MAILED
12/19/2018
CNFR
FINAL REFUSAL WRITTEN
12/19/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/15/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/15/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/15/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/15/2018
GNRT
NON-FINAL ACTION E-MAILED
05/15/2018
CNRT
NON-FINAL ACTION WRITTEN
05/15/2018
DOCK
ASSIGNED TO EXAMINER
05/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/08/2018
NWAP
NEW APPLICATION ENTERED
02/01/2018
Continuous trademark protection
Get notified about every new filing that threatens RXDISPENSE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.